PubMed Health⌕ Search

PubMed · 12766821

[Cataract and keratoplasty--simultaneous or sequential surgery?].

Abstract

BACKGROUND AND PURPOSE: Since the introduction of the triple procedure (simultaneous penetrating keratoplasty [PK], extracapsular cataract extraction [CE] and implantation of a posterior chamber intraocular lens [PCIOL]) in the mid-seventies, there is an ongoing discussion among corneal surgeons concerning the best approach for combined corneal disease and cataract. METHODS: Besides the classical triple procedure (1), two alternative microsurgical approaches are feasible: (2) CE + PCIOL prior to PK and (3) CE + PCIOL after PK. For the refractive results after TRIPLE some intraoperative details are crucial: Trephination of recipient and donor from the epithelial side without major oversize (Guided Trephine System or Nonmechanical Excimer Laser Trephination) should preserve the preoperative corneal curvature. Graft and the PCIOL placed in the bag after continuous curvilinear capsulorhexis should be centered along the optical axis. If possible, performing the capsulorhexis under controlled intraocular pressure conditions prior to trephination may help to minimise the risk of capsular ruptures. RESULTS: The major advantage of the TRIPLE is the faster visual rehabilitation and less efforts for the mostly elderly patients. However, two intraocular interventions with approach (2) and (3) bear an increased risk of infection and suprachoroidal haemorrhage. Approach (2) requires a cornea that is still transparent enough to perform cataract surgery, and the risk of intraocular pressure rise after PK seems to be increased. Approach (3) has the potential of a simultaneous reduction of astigmatism during CE (appropriate location of the incision, simultaneous refractive keratotomies or implantation of a toric PCIOL). Disadvantages may include the loss of graft endothelial cells and the theoretically increased risk of immunological allograft reactions. After TRIPLE, major deviations from target refraction have been reported. However, individual multiple regression analysis may help to minimise this problem with appropriate methods of trephination. Since suture removal after PK may result in major individual changes of the corneal curvature, IOL power calculation for approach (3) requires all sutures to be removed at the time of CE. However, even after complete suture removal the abnormal proportions between anterior and posterior curvatures and/or the irregular topographies after PK may be responsible for marked IOL power miscalculations in the individual case. CONCLUSIONS: The postulated better refractive outcome and better uncorrected visual acuity after the sequential approach is opposed by a markedly delayed visual rehabilitation. For this reason, we consider the TRIPLE procedure including CE via open sky in general anesthesia as the method of choice for combined lens and corneal opacities. Because of the often rapidly progressive nuclear cataracts after PK, we recommend the simultaneous approach in elderly patients with Fuchs' dystrophy even with incipient lens opacities.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Berthold Seitz, Achim Langenbucher, Anja Viestenz, Tina Dietrich, Michael Küchle, Gottfried O H Naumann. 2003. [Cataract and keratoplasty--simultaneous or sequential surgery?].. https://doi.org/10.1055/s-2003-39429

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment.

IMPORTANCE: Blood-based biomarkers for Alzheimer disease, particularly plasma phosphorylated tau 217 (p-tau217), accurately reflect early Alzheimer disease brain pathology in cognitively unimpaired individuals, but estimates of absolute risk of progression to cognitive impairment across multiple cohorts are needed. OBJECTIVE: To estimate absolute risk of progression to cognitive impairment and rates of cognitive decline based on plasma p-tau217 across cognitively unimpaired older adults. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal cohort study using harmonized data from 2684 cognitively unimpaired older adults (defined within cohort) across 6 observational and clinical trial cohorts based in North America, Japan, and Australia. The earliest enrollment was in 2004, with most recent follow-up in 2025. EXPOSURE: Baseline plasma p-tau217. MAIN OUTCOMES AND MEASURES: The primary outcome was time to progression to cognitive impairment (mild cognitive impairment, dementia, or 2 consecutive global Clinical Dementia Rating scores ≥0.5). The secondary outcome was longitudinal change on the latent Preclinical Alzheimer Cognitive Composite (PACC; higher values indicate better performance). RESULTS: Among the 2684 participants (median [IQR] age, 69.6 [66.2-74.2] years; 1697 [63%] female), there were 478 events of progression to cognitive impairment over a median follow-up of 5.4 years (maximum follow-up of 13.5 years). Each 1-SD increase in baseline p-tau217 level was associated with an increased risk of progression to cognitive impairment (hazard ratio, 1.38 [95% CI, 1.30-1.46]), and the association remained significant after adjustment, including β-amyloid positron emission tomography scan Centiloids (hazard ratio, 1.32 [95% CI, 1.24-1.41]). Participants with high (1.1-2.4 SD) and very high (>2.5 SD) baseline p-tau217 had 24% (95% CI, 20%-28%) and 38% (95% CI, 33%-43%) absolute risk of progression over 5 years, respectively, and risk was markedly higher over 10 years, although longer-term estimates were constrained by limited data. Elevated p-tau217 was also associated with faster cognitive decline based on change in latent PACC score. Among the overall sample, baseline latent PACC scores ranged from -0.8 to 2.7. The 5-year annualized decline for the very high p-tau217 group was -0.07 latent PACC units/y (95% CI, -0.10 to -0.05), relative to 0.03 units/y (95% CI, 0.02-0.04) in the low p-tau217 group. CONCLUSIONS AND RELEVANCE: In a pooled sample of multiple selected cohorts of cognitively unimpaired older adults, higher plasma p-tau217 levels were consistently associated with increased risk of clinical progression and accelerated cognitive decline. By providing time-specific absolute risk estimates, these findings support the potential of p-tau217 for prognostic model development, with direct implications for future trial design. Further validation in unselected populations is needed to inform individual prognosis and clinical decision-making in cognitively unimpaired individuals.

Aged↗

Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer.

OBJECTIVE: Lifestyle and anthropometric factors may influence prostate cancer (PCa) risk, yet evidence remains inconclusive. This study reports the associations between lifestyle and anthropometric factors and clinically significant PCa (csPCa; ISUP grade > 1) among men with clinical suspicion of PCa. MATERIALS AND METHODS: In this registered (NCT06116851), single-institution, prospective cohort trial, men referred for PCa diagnostics due to elevated prostate-specific antigen or abnormal digital rectal examination were included. Subjects underwent prostate diagnostics and completed detailed surveys of lifestyle, medical and family history. Physical activity was measured using a triaxial accelerometer. Anthropometric assessments included body mass index, waist circumference and magnetic resonance imaging-based body composition analyses. RESULTS: Among 298 included men, 143 (48%) were diagnosed with csPCa. In multivariate logistic regression, higher physical activity, measured by step count (odds ratio [OR]: 0.91, 95% confidence interval [CI]: 0.82-0.99) and active smoking compared to never-smokers (OR: 0.38, 95% CI: 0.14-0.96) were inversely associated with detection of csPCa. Higher prostate-specific antigen density was associated with increased risk (OR: 1.78, 95% CI: 1.39-2.35). Body composition was not associated with csPCa. Study strengths include comprehensive data collection. Primary limitation is partial reliance on self-reported data. CONCLUSIONS: Higher measured physical activity was inversely associated with detection of csPCa in men with suspicion of PCa. Active smoking also showed an inverse association. Both findings merit further investigation.

Aged↗

Oral and gut microbiota profiles in patients with locally advanced rectal cancer with varying responses to neoadjuvant chemoradiotherapy.

Recent research has focused on gut bacteria in colorectal cancer, but the influence of other microbiota, including oral and nonbacterial gut microbiota, on treatment efficacy remains insufficiently explored. This study aimed to investigate their relationship with the efficacy of neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC). Saliva and fecal samples were collected from patients with LARC before treatment. Shotgun metagenomic sequencing was used to profile bacterial, archaeal, eukaryotic, and viral taxonomic groups and to examine oral and gut microbial functions. An artificial intelligence-based prediction model was developed by integrating oral and gut microbiome data with clinical information. Statistical analyses compared diversity and response-associated microbial features between responders and non-responders to nCRT. Response-associated differences were observed in bacterial and nonbacterial taxonomic profiles and in oral and gut microbial functional profiles. In the internal test subset, the integrated analysis yielded an observed AUC of 0.917. Given the small cohort and the exploratory comparison of candidate classifiers, this estimate requires confirmation in larger, independent cohorts. Baseline oral and gut microbiome profiles were associated with response to nCRT. Integrating microbiome and clinical features showed potential for response prediction, but the model remains exploratory and requires validation in larger, independent cohorts before clinical application. Retrospectively registered on 01/08/2026, NCT07346729.

Aged↗